Mathew S Maurer

58PUBLICATIONS
313CO-AUTHORS
Gene and molecular therapyPeripheral nervous systemAutoimmunityCardiology (incl. cardiovascular diseases)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (58)

|Oct 05, 2026
Emerging therapies and translational tools for drug development in systemic amyloidosis: insights from the International Society of Amyloidosis Scientific Workshop.

|Sep 15, 2026
Eplontersen with and without background transthyretin stabilizers in transthyretin amyloid cardiomyopathy: secondary analysis of a phase 3, randomized controlled trial.

|Sep 12, 2026
Phenotypic Considerations for Tafamidis Use in a Real-World Cohort of Older Patients with Transthyretin Amyloid Cardiomyopathy.

|Sep 10, 2026
Proteomics Profiling Reveals Molecular Subtypes of Transthyretin Cardiac Amyloidosis.

|Sep 04, 2026
Impact of Baseline Polyneuropathy Severity on Eplontersen Efficacy in the NEURO-TTRansform Clinical Trial.

|Aug 30, 2026
Effect of Anselamimab on Cardiac Structure and Function in Patients With Light Chain Amyloidosis: Insights From the CARES Clinical Trials.

Pageof 10

Frequent Collaborators

12 joint publications

Pablo Garcia-Pavia

11 joint publications

Marianna Fontana

9 joint publications

Ahmad Masri

8 joint publications

Scott D Solomon